| Code | Description | Claims | Beneficiaries | Total Paid |
| 20610 |
|
4,836 |
2,981 |
$105K |
| 76942 |
|
5,175 |
3,277 |
$71K |
| J3304 |
Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg |
403 |
385 |
$42K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
6,857 |
6,058 |
$39K |
| 20553 |
|
1,247 |
1,159 |
$26K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
3,561 |
3,135 |
$12K |
| J0897 |
Injection, denosumab, 1 mg |
25 |
25 |
$7K |
| J7321 |
Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose |
525 |
229 |
$7K |
| J7324 |
Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose |
70 |
24 |
$4K |
| J7320 |
Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg |
118 |
52 |
$3K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
703 |
679 |
$2K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
2,513 |
1,403 |
$2K |
| 99205 |
Prolong outpt/office vis |
57 |
57 |
$667.75 |
| 76970 |
|
17 |
17 |
$43.43 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
12 |
12 |
$0.00 |